Instrument Inactif

Communiqués CannaVEST Corp OTC Bulletin Board

Actions

US1376531018

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

07/06	CV Sciences, Inc. élit Bill McCorkle au poste d'administrateur	CI
03/06	Transcript : CV Sciences, Inc. - Shareholder/Analyst Call

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

CV Sciences, Inc. Reports First Quarter 2024 Financial Results	14/05	PR
CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER	14/05	PR
CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024	08/05	PR
CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results	28/03	PR
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024	21/03	PR
CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European Distribution	12/12	PR
CV Sciences, Inc. Reports Third Quarter 2023 Financial Results	14/11	PR
CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023	09/11	PR
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results	14/08/23	PR
CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023	01/08/23	PR
CV SCIENCES, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	05/06/23	AQ
CV Sciences, Inc. Reports First Quarter 2023 Financial Results	15/05/23	PR
CV SCIENCES, INC. TO ANNOUNCE FIRST QUARTER 2023 RESULTS ON MAY 15, 2023	09/05/23	PR
CV Sciences, Inc. Introduces New THC Offering	03/04/23	PR
CV SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	30/03/23	AQ
CV SCIENCES, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	29/03/23	AQ
CV Sciences, Inc. Reports Fiscal Year-End 2022 Financial Results	29/03/23	PR
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023	25/03/23	PR
CV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco Addiction	23/03/23	PR
CV Sciences, Inc. Launches New Line of THC-Free Gummies and Softgels	21/03/23	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués CannaVEST Corp OTC Bulletin Board

Actions

US1376531018

Communiqués

Filtres